GlassScriptPhysician profile
Ari S Levine
NPI 1235526211
$843.17
in general payments reported to CMS, 2019-2025
16 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.67 · 2022: $97.32 · 2023: $268 · 2024: $154 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $132.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $131.98 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $107.85 | 2022-2024 | Mounjaro, Trulicity, Jardiance |
| Glaxosmithkline, LLC. | $80.53 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Baxter Healthcare | $63.21 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $60.34 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $59.19 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $37.75 | 2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $30.59 | 2023 | Quviviq |
| Pfizer INC. | $29.18 | 2023 | |
| Inspire Medical Systems, INC. | $25.36 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.39 | 2022 | |
| Amgen INC. | $20.60 | 2025 | Repatha, Otezla |
| Currax Pharmaceuticals LLC | $15.83 | 2024 | Onzetra Xsail, Contrave |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.63 | 2025 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.